Literature DB >> 26372591

Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply.

Willemijn J Jansen1, Rik Ossenkoppele2, Pieter Jelle Visser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26372591     DOI： 10.1001/jama.2015.9719

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Developing therapeutic vaccines against Alzheimer's disease.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Expert Rev Vaccines       Date:  2015-12-11       Impact factor: 5.217

2.  Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.

Authors:  Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

Review 3.  The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease.

Authors:  Cristina Lopez Lopez; Pierre N Tariot; Angelika Caputo; Jessica B Langbaum; Fonda Liu; Marie-Emmanuelle Riviere; Carolyn Langlois; Marie-Laure Rouzade-Dominguez; Martin Zalesak; Suzanne Hendrix; Ronald G Thomas; Vissia Viglietta; Rob Lenz; J Michael Ryan; Ana Graf; Eric M Reiman
Journal:  Alzheimers Dement (N Y)       Date:  2019-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.